Royal London Asset Management’s Zimmer Biomet ZBH Stock Holding History

Royal London Asset Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8.24M	Buy	91,118 +9,876	+12%	+$906K	0.02%	484
2025 Q4	$7.31M	Sell	81,242 -1,584	-2%	-$150K	0.02%	494
2025 Q3	$8.16M	Sell	82,826 -2,864	-3%	-$284K	0.02%	480
2025 Q2	$7.82M	Sell	85,690 -8,107	-9%	-$784K	0.02%	478
2025 Q1	$10.6M	Buy	93,797 +7,401	+9%	+$792K	0.03%	429
2024 Q4	$9.13M	Buy	86,396 +2,211	+3%	+$237K	0.02%	435
2024 Q3	$9.09M	Buy	84,185 +2,084	+3%	+$227K	0.02%	442
2024 Q2	$8.91M	Sell	82,101 -565	-0.7%	-$66.6K	0.02%	417
2024 Q1	$10.9M	Sell	82,666 -293	-0.4%	-$36.6K	0.03%	380
2023 Q4	$10.1M	Buy	82,959 +2,915	+4%	+$325K	0.03%	384
2023 Q3	$8.98M	Buy	80,044 +3,285	+4%	+$417K	0.03%	388
2023 Q2	$11.2M	Buy	76,759 +2,889	+4%	+$393K	0.04%	341
2023 Q1	$9.54M	Buy	73,870 +1,668	+2%	+$209K	0.04%	337
2022 Q4	$9.2M	Buy	72,202 +2,224	+3%	+$258K	0.04%	338
2022 Q3	$7.33M	Sell	69,978 -4,210	-6%	-$462K	0.04%	354
2022 Q2	$7.8M	Sell	74,188 -9,036	-11%	-$1.07M	0.04%	348
2022 Q1	$10.6M	Buy	83,224 +7,379	+10%	+$889K	0.04%	325
2021 Q4	$9.35M	Hold	75,845	–	–	0.03%	351
2021 Q3	$10.8M	Sell	75,845 -3,931	-5%	-$578K	0.04%	314
2021 Q2	$12.5M	Hold	79,776	–	–	0.05%	294
2021 Q1	$12.4M	Buy	79,776 +1,984	+3%	+$307K	0.06%	274
2020 Q4	$11.6M	Sell	77,792 -758	-1%	-$107K	0.06%	264
2020 Q3	$10.2M	Hold	78,550	–	–	0.06%	249
2020 Q2	$8.92M	Sell	78,550 -4,181	-5%	-$482K	0.06%	270
2020 Q1	$7.89M	Sell	82,731 -417	-0.5%	-$54.7K	0.06%	265
2019 Q4	$12M	Hold	83,148	–	–	0.08%	230
2019 Q3	$11.1M	Sell	83,148 -1,513	-2%	-$195K	0.08%	244
2019 Q2	$9.67M	Sell	84,661 -2,394	-3%	-$280K	0.09%	223
2019 Q1	$10.8M	Sell	87,055 -1,722	-2%	-$196K	0.09%	235
2018 Q4	$8.85M	Buy	88,777 +2,873	+3%	+$323K	0.08%	259
2018 Q3	$11M	Sell	85,904 -1,636	-2%	-$195K	0.11%	188
2018 Q2	$9.47M	Buy	+87,540	New	+$9.53M	0.1%	229
2016 Q2	$7.51M	Sell	64,269 -4,590,397	-99%	-$520M	0.12%	187
2016 Q1	$42K	Buy	4,654,666 +4,590,117	+7,111%	+$444M	0.06%	339
2015 Q4	$6.42M	Sell	64,549 -77	-0.1%	-$7.53K	0.1%	216
2015 Q3	$5.89M	Buy	+64,626	New	+$6.48M	0.1%	230
2014 Q4	$60K	Buy	53,958 +11,296	+26%	+$1.19M	0.11%	209
2014 Q3	$4.2M	Buy	42,662 +2,361	+6%	+$232K	0.11%	211
2014 Q2	$3.77M	Sell	40,301 -181	-0.4%	-$17.7K	0.09%	248
2014 Q1	$3.96M	Sell	40,482 -1,064	-3%	-$98.1K	0.09%	234
2013 Q4	$3.9M	Buy	41,546 +367	+0.9%	+$31.8K	0.1%	230
2013 Q3	$3.42M	Buy	41,179 +562	+1%	+$44.2K	0.09%	248
2013 Q2	$2.96M	Buy	+40,617	New	+$3.04M	0.09%	270

Other funds holding ZBH

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Royal London Asset Management's ZBH Position: Q1 2026 in Review

Royal London Asset Management increased its Zimmer Biomet (ZBH) stake by 12% in Q1 2026, buying an estimated $906K and bringing the position to 91,118 shares worth $8.24M. The position accounts for 0.02% of the portfolio, ranked #484.

Royal London Asset Management first reported a position in ZBH in Q2 2013 and has held it in 43 quarters since. The position peaked at $12.5M in Q2 2021. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

Royal London Asset Management held 91,118 shares of Zimmer Biomet worth $8.24M as of Q1 2026.
Royal London Asset Management bought 9,876 Zimmer Biomet shares in Q1 2026, an estimated $906K.
Zimmer Biomet made up 0.02% of Royal London Asset Management's portfolio in Q1 2026, its #484 holding.
Royal London Asset Management first reported a position in Zimmer Biomet in Q2 2013 and has held it in 43 quarters since.
Royal London Asset Management's Zimmer Biomet position peaked at $12.5M in Q2 2021.
912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Royal London Asset Management's 13F filing for Q1 2026, filed 1 May 2026.